Celltrion Pharm Inc
KOSDAQ:068760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
KR |
|
G
|
Guangdong TianYiMa Information Industry Co Ltd
SZSE:301178
|
CN |
|
Manawa Energy Ltd
NZX:MNW
|
NZ |
|
A
|
ACI Worldwide Inc
XBER:TSA
|
US |
|
BGR Energy Systems Ltd
NSE:BGRENERGY
|
IN |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Rua Life Sciences PLC
LSE:RUA
|
UK |
|
G
|
Go Metals Corp
OTC:GOCOF
|
CA |
|
F
|
Fitness Champs Holdings Ltd
NASDAQ:FCHL
|
SG |
|
Link and Motivation Inc
TSE:2170
|
JP |
|
S
|
Sigma Energy Compressindo Tbk PT
IDX:SICO
|
ID |
|
Jungfraubahn Holding AG
SIX:JFN
|
CH |
|
Samsung Electronics Co Ltd
BMV:SMSNN
|
KR |
|
G
|
Grahaprima Suksesmandiri Tbk PT
IDX:GTRA
|
ID |
|
L
|
Lila Kagit Sanayi ve Ticaret AS
IST:LILAK.E
|
TR |
|
Hamilton Thorne Ltd
XTSX:HTL
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Celltrion Pharm Inc's stock price target?
Not Available
Celltrion Pharm Inc doesn't have any price targets made by Wall Street professionals.
What is Celltrion Pharm Inc's Revenue forecast?
Projected CAGR
10%
For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's revenue is 20%. The projected CAGR for the next 7 years is 10%.
What is Celltrion Pharm Inc's Operating Income forecast?
Projected CAGR
45%
For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's operating income is 15%. The projected CAGR for the next 7 years is 45%.
What is Celltrion Pharm Inc's Net Income forecast?
Projected CAGR
26%
For the last 13 years the compound annual growth rate for Celltrion Pharm Inc's net income is 15%. The projected CAGR for the next 7 years is 26%.
